1. Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations. Issue 11 (2nd November 2017) Authors: Gatti-Mays, Margaret E.; Redman, Jason M.; Collins, Julie M.; Bilusic, Marijo Journal: Human vaccines & immunotherapeutics Issue: Volume 13:Issue 11(2017) Page Start: 2561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy. (3rd August 2018) Authors: Collins, Julie M.; Redman, Jason M.; Gulley, James L. Journal: Expert review of vaccines Issue: Volume 17:Number 8(2018) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Emergent Renal Dysfunction with Colistin Pharmacotherapy. Issue 8 (18th April 2013) Authors: Collins, Julie M.; Haynes, Kevin; Gallagher, Jason C. Journal: Pharmacotherapy Issue: Volume 33:Issue 8(2013) Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer. Issue 8 (11th July 2020) Authors: Collins, Julie M.; Isaacs, Claudine Journal: Breast journal Issue: Volume 26:Issue 8(2020) Page Start: 1520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors. (26th December 2019) Authors: Collins, Julie M.; Donahue, Renee N.; Tsai, Yo‐Ting; Manu, Michell; Palena, Claudia; Gatti‐Mays, Margaret E.; Marté, Jennifer L.; Madan, Ravi A.; Karzai, Fatima; Heery, Christopher R.; Strauss, Julius; Abdul‐Sater, Houssein; Cordes, Lisa; Schlom, Jeffrey; Gulley, James L.; Bilusic, Marijo Journal: Oncologist Issue: Volume 25:Number 7(2020) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. Issue 1 (5th September 2019) Authors: Bilusic, Marijo; Heery, Christopher R.; Collins, Julie M.; Donahue, Renee N.; Palena, Claudia; Madan, Ravi A.; Karzai, Fatima; Marté, Jennifer L.; Strauss, Julius; Gatti-Mays, Margaret E.; Schlom, Jeffrey; Gulley, James L. Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Product review: avelumab, an anti-PD-L1 antibody. Issue 4 (3rd April 2019) Authors: Collins, Julie M.; Gulley, James L. Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 4(2019) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗